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Abstract. 
 
The nuclear lamina is a protein meshwork 
lining the nucleoplasmic face of the inner nuclear mem-
brane and represents an important determinant of in-
terphase nuclear architecture. Its major components 
are the A- and B-type lamins. Whereas B-type lamins 
are found in all mammalian cells, A-type lamin expres-
sion is developmentally regulated. In the mouse, A-type 
lamins do not appear until midway through embryonic 
development, suggesting that these proteins may be in-
volved in the regulation of terminal differentiation. 
Here we show that mice lacking A-type lamins develop 
to term with no overt abnormalities. However, their 
postnatal growth is severely retarded and is character-
ized by the appearance of muscular dystrophy. This 
phenotype is associated with ultrastructural perturba-
tions to the nuclear envelope. These include the mislo-
calization of emerin, an inner nuclear membrane pro-
tein, defects in which are implicated in Emery-Dreifuss 
muscular dystrophy (EDMD), one of the three major 
X-linked dystrophies. Mice lacking the A-type lamins 
exhibit tissue-speciﬁc alterations to their nuclear enve-
lope integrity and emerin distribution. In skeletal and 
cardiac muscles, this is manifest as a dystrophic condi-
tion related to EDMD.
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T
 
HE
 
 vertebrate nuclear lamina is a thin (10–20 nm)
protein meshwork associated with the nuclear face
of the inner nuclear membrane (INM).
 
1
 
 Because of
its role in maintaining nuclear envelope (NE) integrity and
in providing anchoring sites for chromatin domains, the
lamina is considered to represent an important deter-
minant of interphase nuclear architecture (Gerace and
Burke, 1988; Gant and Wilson, 1997). The major compo-
nents of the lamina are intermediate filament-like proteins,
the nuclear lamins. Most adult mammalian somatic cells
contain three major lamins, A, B1, and C, as well as sev-
 
eral minor lamins (B2 and A
 
D
 
10). These various forms are
 
grouped into two classes, A-type (A, A
 
D
 
10 and C) and
B-type (B1 and B2). Lamins B1 and B2 are encoded by
separate genes, whereas all of the A-type lamins are en-
coded by a single gene and arise through alternative splic-
ing of a common transcript (Moir et al., 1995; Stuurman et
al., 1998).
While B-type lamins are found in all nucleated somatic
cells, the expression of A-type lamins is developmentally
regulated. In the mouse, A-type lamins are absent from
all preimplantation stage embryonic cells (including em-
bryonal carcinoma [EC] cells), with their synthesis com-
mencing at about embryonic day 9 within the visceral
endoderm and trophoblast (Stewart and Burke, 1987).
Subsequently, A-type lamins appear asynchronously in
various tissues with certain cell types not acquiring these
proteins until after birth (Rober et al., 1989). A few, nota-
bly cells of the immune system, pancreatic islets and
Purkinje cells, only express B-type lamins (Rober et al.,
1990). These findings indicate that at the cellular level,
A-type lamins are nonessential. However, the significance
of these observations and how they relate to lamin func-
tion remain uncertain. While it has often been suggested
that A-type lamins are involved in terminal differentia-
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tion, possibly as determinants of chromatin organization,
this notion has never been tested.
Here, we report the derivation of mice in which the
A-type lamins has been eliminated by gene targeting. Al-
though these mice exhibit overtly normal embryonic de-
velopment, their postnatal growth is marked by the rapid
onset of muscular dystrophy. This condition is associated
with aberrant localization of emerin, an INM protein
linked to human Emery-Dreifuss muscular dystrophy
(EDMD). Therefore, these mice provide new insights into
the relationship between lamins, INM proteins, and their
role in EDMD, as well as provide a unique model for the
autosomal variant of this disease (Bonne et al., 1999).
 
Materials and Methods
 
Targeted Disruption of Lamin A/C Gene
 
An 8.6-kb fragment containing exons 2–12 was isolated from a 129/Sv
mouse liver genomic library. To produce the targeting vector, an NsiI-
BamHI fragment was deleted, removing exons 8 to part of 11, and re-
placed with the 
 
Pgkneo 
 
neomycin resistance cassette in reverse orienta-
tion to the 
 
Lmna
 
 gene. The targeting vector was linearized with ClaI and
electroporated into W9.5 ES cells. Clones were picked, expanded, and
screened for homologous recombinants, after digestion with EcoRI, using
a probe to exon 2. Two clones were injected into C57Bl/6 blastocysts, and
chimeras were derived and bred to produce germline offspring as de-
scribed (Stewart, 1993). Homozygotes and heterozygotes were distin-
guished from wild-type sibs by EcoRI digestion of tail DNA.
 
Transfection
 
A human lamin A cDNA was subcloned into the pTracer-CMV vector
(Invitrogen Corp.). The linearized vector was transfected into lamin A/C
 
2
 
/
 
2
 
 mouse embryonic fibroblasts (MEFs). Stable clones were selected us-
ing Zeocin, according to the manufacturer’s instructions and the clones
pooled. Subsequent analysis showed that the cells in the pool were hetero-
geneous with regard to lamin A expression.
 
Antibodies
 
The antibody to mouse emerin was provided by Dr. Glenn Morris (NE
Wales Institute, UK). Dr. Erich Nigg (University of Geneva) provided the
antibody against lamin B2. Dr. Larry Gerace (Scripps Institute) provided
both antibodies against LAP2 and an antibody against lamin B. The anti-
bodies SA1 (specific for Nup153) and XB10 (against the lamin A/C cen-
 
tral rod domain) have been described previously (Horton et al., 1992; Bo-
door et al., 1999). Dr. Frank McKeon provided the 1E4 antibody to the
amino terminal region of lamins A and C. The rhodamine and FITC-con-
jugated secondary antibodies were from Tago, Inc. 
 
Histology and Immunohistochemistry
 
Tissues and cells were fixed in 10% buffered formalin or 3% paraformal-
dehyde in PBS respectively. Tissues for immunohistochemical analysis
were embedded in OCT and snap frozen. Tissues for histological analysis
were dehydrated, cleared, embedded in paraffin, sectioned at 6 microns,
and stained in hematoxylin/eosin. MEFs were processed for immunofluo-
rescence microscopy as previously described (Ash et al., 1977).
 
Electron Microscopy
 
The in situ processing of cultured cells was modified from a previously de-
scribed method (Gonda et al., 1976). Epon sections (50 nm), stained with
uranyl acetate and lead citrate, were examined and photographed at 75 kV.
 
Results and Discussion
 
To mutate the mouse lamin A/C (
 
Lmna
 
) gene, we deleted
a region extending from exon 8 to the middle of exon 11.
This removed 114 codons as well as the 3
 
9
 
 untranslated se-
quence, including the polyadenylation signal of lamin C,
whereas 152 codons were eliminated from the lamin A
coding region. The deletion was introduced by homolo-
gous recombination into ES cells and six homologous re-
combinant clones were identified (Fig. 1, a and b). After
blastocyst injection of two clones, chimeric offspring were
derived with subsequent germline transmission of the mu-
tated allele. Heterozygotes were intercrossed to derive vi-
able homozygous offspring. At birth, these were indistin-
guishable from their heterozygous or wild-type siblings.
Loss of lamin A/C expression was determined by West-
ern blot analysis of cell extracts, nuclei, or NEs prepared
from the livers of weaned offspring or from embryonic
fibroblasts (MEFs) established from day 13 embryos.
Whereas NEs could be readily prepared from the livers of
mice heterozygous and wild-type for the 
 
Lmna
 
 gene, they
could not be isolated in an intact form from the lamin null
mice. Instead, the 
 
2
 
/
 
2
 
 NEs fragmented, leading to poor
recovery. Using two independent antibodies against epi-
topes within either the first 250 amino acids or the central
Figure 1. Targeting of the Lmna gene. (a) Struc-
ture of the mouse Lmna gene, together with the
targeting vector and homologous recombinant
containing the PgkNeo cassette. (b) Southern
analysis of the representative genotypes from
Lmna heterozygote crosses. (c) Northern analy-
sis from wild-type and Lmna null fibroblasts
showing loss of full length forms of lamin A and
C mRNAs. These are replaced by truncated
transcripts at levels 10 fold below those of wild
type. (d) Western analysis, with the XB10 anti-
body (to the central domain of lamin A/C) of nu-
clear extracts from MEFs of all three genotypes
showing that lamin A and C proteins were unde-
tectable in the 2/2 fibroblasts, whereas lamin B
levels were unaffected. P19 EC cells were used
as a negative control. (e) Western analysis, using
the 1E4 antibody (against the lamin A/C amino-
terminal region) of liver nuclei and nuclear enve-
lopes showing, as in the MEFs’ absence of the
lamin A proteins. 
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rod domain of lamin A/C (1E4 and XB10, respectively)
(McKeon et al., 1986; Horton et al., 1992), proteins of the
appropriate molecular masses were undetectable in any of
the samples prepared from tissues homozygous for the
mutated gene. Neither was there any evidence for trun-
cated forms of the two proteins. Lamin B1 levels in all of
the cell types remained unaltered (Fig. 1, d and e). North-
ern blot analysis of poly(A)
 
1 
 
mRNA from 
 
2
 
/
 
2
 
 livers re-
vealed two faster migrating faint bands at levels 10-fold
lower than the wild-type lamin A and C transcripts (Fig. 1
c). Taken together, these results indicate that the partial
deletion of the 
 
Lmna
 
 gene resulted in the absence of both
full-length transcripts and stable lamin A/C proteins.
These results were confirmed by immunocytochemistry
since neither of the two anti–lamin A/C antibodies labeled
the NEs of the 
 
Lmna
 
 
 
2
 
/
 
2
 
 MEFs (Fig. 2 a). In contrast,
lamins B1 and B2 were readily detected (Fig. 2, d and
e).  These labeling experiments also revealed dramatic
changes in nuclear morphology. Whereas nuclei of wild-
type MEFs are roughly circular or slightly ovoid, those of
 
Lmna
 
 
 
2
 
/
 
2
 
 MEFs are often highly elongated or irregular
and exhibit loss of B-type lamins from one pole (Fig. 2, d
and e). Although the nuclei remain intact, the overall im-
pression is of large-scale herniation of the nuclear mem-
branes. This abnormality, evident in 
 
.
 
80% of the 
 
2
 
/
 
2
 
MEF nuclei, is apparent in Fig. 2 e, where Nomarski and
lamin B immunofluorescence images are superimposed.
Similar results were obtained with antibodies against both
the inner nuclear membrane protein LAP2 (Foisner and
Gerace, 1993) and the nuclear pore complex (NPC) pro-
tein Nup153 (Bodoor et al., 1999) (Fig. 2, b and c). The lat-
ter also revealed a slight degree of NPC clustering within
some 
 
2
 
/
 
2
 
 nuclear envelopes. An intermediate phenotype
 
was observed for 
 
1
 
/
 
2
 
 MEFs with frequent elongation of
nuclei, but largely normal distribution of nuclear envelope
proteins (data not shown). Ultrastructural examination of
 
2
 
/
 
2
 
 MEFs and hepatocytes revealed a thinning or loss of
heterochromatin at discrete regions of the nuclear face
of the INM. These segments of the nuclear envelope,
which also lack morphologically identifiable NPCs, likely
correspond to the herniations observed in the light micro-
scope (Fig. 3, a and b). Thus, the integrity of NEs in 
 
2
 
/
 
2
 
cells is profoundly compromised and shows conclusively
for the first time that A-type nuclear lamins are essential
for the maintenance of normal nuclear architecture. This
complements a previous study in 
 
Drosophila
 
 showing that
a B-type lamin is also essential for nuclear integrity (Lenz-
Bohme et al., 1997).
At birth, 
 
Lmna
 
 null mice were indistinguishable from
their heterozygous or wild-type sibs. However, within
2–3 wk a reduction in their growth rate was noted and by
 
z
 
4 wk, despite normal tooth development and the contin-
ued ability to eat, their growth had ceased. At this time
their mean body weight was roughly 50% that of their
wild-type or heterozygous littermates. At 
 
z
 
3–4 wk, the
homozygotes began to display an abnormal gait with a stiff
walking posture, characterized by splayed hind legs and an
inability to hang onto structures with their forepaws. Their
overall posture became progressively more hunched, ex-
hibiting distinct scoliosis/kyphosis. By the eighth week, all
of the homozygotes had died. The heterozygotes are also
apparently normal and have not exhibited any premature
mortality when compared with their wild-type sibs.
Histological analysis of homozygotes revealed that the
majority of their internal organs were normal, although
some thymic atrophy and a reduction in spleen size was
Figure 2. Immunohistochemical analysis of wild-type and Lmna null MEFs. The nuclei in all experiments were labeled with DAPI; in
a–d, DAPI and immunofluorescence images have been superimposed. (a) Lamins A and C were detected with the XB10 mAb. (b) Nu-
clear lamina–associated protein, LAP2. Note the uniform distribution of this protein in wild-type nuclear envelopes, but its loss from
one pole of the irregularly shaped nuclei in the Lmna null cells. (c) Nuclear pore complex Nup153. As with LAP2, there is loss from one
pole of the nucleus, indicating exclusion of NPCs from this region. (d and e) Lamin B. Exclusion of this protein from one pole of the nu-
cleus is clearly seen in the Lmna null cells. In e, the immunofluorescence image showing lamin B distribution (Lamin B*) has been su-
perimposed on the Nomarski image of the same cell. Note that the two panels in e show complementary images of the same Lmna null
cell. The lower panel shows DAPI labeling only. 
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evident as was an absence of white fat, possibly as a sec-
ondary consequence of physiological stress. The wild-type
and heterozygous mice exhibited no overt abnormalities.
Examination of the musculature of the homozygote nulls
revealed that the perivertebral muscles and those sur-
rounding the femur (rectus femoris and semimembranous)
were dystrophic. The involvement of individual fibers
within each muscle was not uniform with those proximal
to the bone being the most severely impaired. Many of
these were atrophic with others exhibiting signs of degen-
eration with hyalin or flocculent cytoplasm. The dystro-
phic muscle fibers also exhibited variations in diameter,
plus an increase in the number of nuclei with some being
centrally located within the fibers (Fig. 4 b). Muscles of the
head, tongue, and diaphragm were largely unaffected. In
the heart, the ventricular muscle was most severely com-
promised although myocyte involvement was nonuniform.
Some were of normal size, but had degenerated with con-
densed or flocculent eosinophilic or vacuolated cytoplasm
(Fig. 4 d). These were often associated with patchy miner-
alization. Other cardiac myocytes were clearly atrophic.
The 
 
Lmna
 
 null mice did not exhibit elevated serum cre-
atine kinase levels, a feature associated with some but not
all forms of muscular dystrophy (data not shown) (Bul-
field et al., 1984). Overall, the 
 
Lmna
 
 
 
2
 
/
 
2
 
 mice develop a
cardiac and skeletal myopathy bearing a striking resem-
blance to human EDMD (Wehnert and Muntoni, 1999).
EDMD was originally described as an X-linked disorder
that mapped to the gene for emerin, a ubiquitous INM
protein (Bione et al., 1994). While the function of emerin
is unknown, the finding that A-type lamin defects result in
an EDMD-like disorder suggests these proteins might
functionally interact. Consistent with this, a recent study
by Bonne et al. (1999) revealed that in humans an autoso-
mal variant of EDMD maps to the lamin A/C (
 
LMNA
 
)
gene. Since the localization of integral proteins to the INM
is thought to involve a process of selective retention (Pow-
ell and Burke, 1990; Ellenberg et al., 1997; Yang et al.,
1997), it is possible that A-type lamins serve to immobilize
emerin within the INM. Therefore, we examined the dis-
tribution of emerin in wild-type and lamin A/C 
 
2
 
/
 
2
 
MEFs. While the overall levels of emerin in these cells is
identical (Fig. 5 a), immunofluorescence microscopy re-
vealed dramatic differences in emerin subcellular localiza-
tion. In wild-type cells, emerin is concentrated within the
nuclear envelope (Manilal et al., 1996; Nagano et al., 1996)
(Fig. 5 b). In the 
 
2
 
/
 
2
 
 cells, there is partial loss of NE-asso-
ciated emerin with a more general cytoplasmic distribu-
tion identical to that observed for resident ER proteins
(Fig. 5 d). Presumably, emerin is no longer retained within
the INM, and is free to access the outer nuclear membrane
and ER via the membrane continuities at the periphery of
NPCs (Ostlund et al., 1999). MEFs from heterozygous em-
bryos exhibited intermediate levels of cytoplasmic emerin
(Fig. 5 c). These results indicate that at least in MEFs, cor-
rect emerin localization is contingent upon A-type lamin
expression. In contrast, LAP2, which shares some se-
quence homology with emerin but which is known to in-
teract with both chromatin and B-type lamins (Furukawa
et al., 1998), still concentrates at the nuclear periphery in
 
2
 
/
 
2
 
 cells (Fig. 2 c).
To further address the role of A-type lamins in emerin
localization, we transfected a human lamin A cDNA into
 
Lmna
 
 null MEFs and followed the distribution of emerin
by double label immunofluorescence microscopy. Fig. 5, e
and f, shows a representative example of two 
 
2
 
/
 
2
 
 MEFs,
only one of which is expressing the heterologous 
 
LMNA
 
.
While emerin in the nonexpressing cell is distributed be-
tween both the NE and the cytoplasm, it is restricted al-
most exclusively to the nuclear periphery in the cell ex-
pressing human lamin A (Fig. 5, g and h). These data
strongly support a role for A-type lamins in the correct lo-
calization of emerin.
Immunocytochemical examination of emerin in several
tissues from the lamin A/C null mice revealed that its nor-
mal nuclear envelope localization was affected in a cell
Figure 3. Electron microscopic analysis of MEFs (a) and hepato-
cytes (b). (a) In the wild-type and heterozygous MEF nuclei, a
largely continuous layer of heterochromatin in contact with the
inner face of the nuclear envelope is visible. In the Lmna null nu-
clei, there are obvious discontinuities in this layer (orange box)
that are juxtaposed to distensions of the nuclear membranes. (b)
Similar discontinuities can be seen in the liver nuclei (arrow). 
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type–specific manner. In tongue epithelium, NE-associ-
ated emerin was completely lost (Fig. 4, i and j), whereas
in skeletal muscle NE-associated emerin was still detect-
able, albeit at a greatly reduced level (Fig. 4, e and f). In
the longitudinal fibers of the ventricular cardiac muscle,
the loss of A-type lamin expression had more heteroge-
neous effects with 
 
z
 
20% of nuclei showing a marked po-
lar clustering of emerin staining (Fig. 4, g and h) that was
particularly apparent in those cells sectioned along their
longitudinal axis. In heterozygous mice, 
 
,
 
0.1% of the ven-
tricular nuclei exhibited emerin polarization and none
were detected in wild-type mice.
These observations reveal a clear role for A-type lamins
in emerin localization. However, NE-associated emerin is
not uniformly lost in tissues from 
 
Lmna
 
 null mice, suggest-
ing the involvement of additional factors. This is sup-
Figure 4. Histological and immunohistochemical
analysis of tissues from Lmna null mice. (a) Wild-
type perivertebral muscle showing the peripheral
localization of the nuclei in the muscle fibers. (b)
Perivertebral muscles from Lmna null mice
showing an increase in nuclear number with
many centrally located within the muscle fibers
(arrows). (c) Wild-type ventricular cardiac mus-
cle. (d) Ventricular muscle from a Lmna null
mouse. (e and f) Emerin (upper panels) localiza-
tion in the skeletal nuclei of wild-type (e) and
lamin  2/2 (f) mice. In the 2/2 muscle, the signal
intensity of emerin in the NE is weaker than in
the 1/1 nuclei. Anti–lamin B labeling is un-
changed (lower panels rhodamine label). (g and
h) Emerin staining in the cardiac nuclei of wild-
type (g) and lmna 2/2 (h) mice. Note the polar
distribution (arrows) of emerin in the 2/2 car-
diac muscle NEs. (i and j) Emerin staining in the
tongue epithelium. In wild-type epithelium,
emerin localization to the NE is readily detect-
able (i), whereas in the lamin null mice it is lost
(j). Nuclei i and j are costained with DAPI. 
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ported by our findings that in P19 embryonal carcinoma
(EC) cells, which do not express A-type lamins at any de-
tectable level (Stewart and Burke, 1987), emerin is, never-
theless, associated with the nuclear periphery (Fig. 5, i and
j). This implies that there is at least one other nuclear en-
velope component with which emerin must be able to in-
teract, and that the level of expression of this component is
likely to be cell type–specific.
EDMD arises from either loss of emerin protein or mu-
tations resulting in its subcellular mislocalization (Ellis et
al., 1998; Fairley et al., 1999), with the rarer autosomally
inherited form being linked to dominant acting mutations
in the 
 
LMNA
 
 gene (Bonne et al., 1999). From this study, it
was not clear whether the NE was disrupted and emerin
localization affected. However, this is a possibility as some
lamin A-type mutants do act in a dominant form, since
their injection or transfection into cells causes severe per-
turbations in nuclear envelope structure and organization
(Spann et al., 1997).
Here, we have shown that an EDMD-like phenotype,
albeit more severe and earlier acting, arises in mice after
ablation of A-type lamin expression. This is associated
with the mislocalization of emerin to varying degrees in
different cell types. Previous observations on the fragility
of purified NEs from P19 EC cells, which don’t express
A-type lamins, indicated a role for the lamins in NE integ-
rity (Horton et al., 1992). In this study, we observed a sim-
ilar, pronounced effect on hepatocyte NEs lacking A-type
lamins with gross structural changes to the NEs and
emerin distribution occurring in a variety of 
 
2
 
/
 
2
 
 cells and
tissues. These observations indicate that in addition to the
lamins, emerin itself may represent another important de-
terminant of interphase NE organization, possibly as a link
between the INM and lamina. However, the relative con-
tributions of the A-type lamins, and emerin either alone or
in combination, to NE integrity remain unclear at the
present. From our studies, loss of the A-type lamins
clearly affects NE integrity. Whether it does so alone or
whether the phenotype is exacerbated by loss/mislocaliza-
tion of emerin, possibly in conjunction with some other tis-
sue-specific and/or developmentally regulated factors will
have to await the derivation of emerin-deficient mice.
Intermediate filament proteins have long been recog-
nized in providing structural integrity to a variety of cells
and tissues. In particular, mutations in members of the cy-
tokeratin gene family are associated with numerous patho-
logical conditions, most notably those of epidermal and
 
Figure 5.
 
(a) Western blot analysis of emerin (34 kD) and lamins
A and C (74 and 65 kD, respectively) in 
 
1
 
/
 
1
 
, 
 
1/2
 
, and 
 
2
 
/
 
2
 
Lmna
 
 MEFs showing no difference in emerin levels between dif-
ferent genotypes. (b) In wild-type cells, emerin is localized exclu-
sively to the nuclear envelope. (c) In the heterozygotes, some
emerin localization can be detected in the cytoplasm. (d) In the
 
lamin A/C 
 
2
 
/
 
2
 
 cells, emerin is largely cytoplasmic although
some localization to the nuclear envelope is still apparent. Ex-
pression of human lamin A in 
 
Lmna
 
 null MEFs results in relocal-
ization of emerin to the nuclear envelope. (e) DAPI staining re-
vealing the nuclei of two MEFs. (f) The upper MEF expresses
human lamin A localized exclusively to the nuclear envelope. (g)
Both cells express emerin but in the lamin A null cell, emerin
is localized predominantly in the cytoplasmic compartment,
whereas in the lamin A positive MEF, emerin is localized almost
entirely to the nuclear envelope. (h) Merged image showing colo-
calization of emerin and human lamin A in the nuclear envelope.
(i and j) Emerin distribution in P19EC cells (i) and (j) their dif-
ferentiated derivatives P19MES that express A-type lamins. Both
cell types exhibit NE-associated emerin.Sullivan et al. A-type Lamin-deficient Mice 919
neurological origin (McLean and Lane, 1995; Galou et al.,
1997; Fuchs and Cleveland, 1998). Here, we have shown
cells lacking A-type lamins, members of the nuclear
branch of the intermediate filament protein family, also
develop a characteristic pathology. However, while these
proteins are expressed in the majority of adult tissues, this
pathology is manifest primarily in the form of muscular
dystrophy. A possible explanation for this is that in the ab-
sence of functional lamins and/or emerin, muscle nuclei
may be unable to withstand the mechanical stresses to
which they are continually subjected. In other tissues,
which do not experience the same contractile forces, while
nuclear envelope integrity may still be compromised, the
effects may be less deleterious. The derivation of mice
with tissue-specific deficiencies in lamina-associated pro-
teins will now allow us to test this suggestion.
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